BBS-Bioactive Bone Substitutes

BBS-Bioactive Bone Substitutes Plc: Conversion of convertible notes pursuant to financing arrangement between BBS and Riverfort Global Opportunities PCC Ltd

MARKN.

BBS-Bioactive Bone Substitutes Plc | Company Release | June 05, 2024 at 13:00:00 EEST

BBS-Bioactive Bone Substitutes Plc: Conversion of convertible notes pursuant to financing arrangement between BBS and Riverfort Global Opportunities PCC Ltd

BBS-Bioactive Bone Substitutes Plc ("BBS") has received 4th June 2024 requests from Riverfort Global Opportunities PCC Ltd ("Riverfort") to convert a proportion of EUR 70,000 of the convertible notes into Company shares at a conversion price of EUR 0.32634 per share. The conversion shall be executed by transferring a total of 214,500 treasury shares to Riverfort.

The Conversion price according to the terms and conditions is “90% of the lowest volume weighted average price of a trading day during ten trading days before the applicable subscription notice“.

After the transfers, the Company will hold a total of 2,147 treasury shares in its possession.

Datum 2024-06-05, kl 12:00
Källa MFN
Kom igång med ditt sparande på bara några minuter! Hos Avanza handlar du aktier från 0 kr på Stockholmsbörsen och får tillbaka alla fondavgifter (ja, alla!) upp till 50 000 kr i samlat sparande. Kanske är det därför Avanza har Sveriges nöjdaste sparare 15 år i rad.
Investeringar innebär en risk